Science Explorer Interactive view Map
Hospital / health system · Dijon · France

Genomic and Immunotherapy Medical Institute

gimi-institute.orgROR OpenAlex
Research works
18
▲ 538% vs 2013–17
Citations
436
24.9 per fractional work
Top-10% rate
42.7%
record average 16.5%
Open access
82%
world 28%

Not ranked overall: Genomic and Immunotherapy Medical Institute is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.64× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 13.12× its world share, 1 worksImmunology and Micro…Neuroscience: 0.70× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.76× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.14× its world share, 0 worksComputer ScienceMedicine: 3.03× its world share, 4 worksMedicineNursing: 0.42× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 13.1×. Every wedge is a field page.

Which research topics does Genomic and Immunotherapy Medical Institute publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Colorectal Cancer Treatments and Studies and Pancreatic and Hepatic Oncology Research.

Cancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksImmune Cell Function and…0Immune Cell Function and Interaction: 0 fractional worksColorectal Cancer Treatm…0Colorectal Cancer Treatments and Studies: 0 fractional worksPancreatic and Hepatic Oncology Research: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksBRCA gene mutations in cancer: 0 fractional worksFerroptosis and cancer prognosis: 0 fractional worksGenomics and Rare Diseases: 0 fractional worksGenetic factors in colorectal cancer: 0 fractional worksPARP inhibition in cancer therapy: 0 fractional works
OncologyImmunologyGeneticsPulmonary and Respiratory Medicine1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 1 works
  2. 2 Immune Cell Function and Interaction Immunology 0 works
  3. 3 Colorectal Cancer Treatments and Studies Oncology 0 works
  4. 4 Pancreatic and Hepatic Oncology Research Oncology 0 works
  5. 5 Immunotherapy and Immune Responses Immunology 0 works
  6. 6 BRCA gene mutations in cancer Genetics 0 works
  7. 7 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  8. 8 Genomics and Rare Diseases Genetics 0 works
  9. 9 Genetic factors in colorectal cancer Pathology and Forensic Medicine 0 works
  10. 10 PARP inhibition in cancer therapy Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available82.5%not open17.5%

World: 28% of research is openly available.

with international co-authors34.4%domestic only65.6%

World: 19% is written across borders.

How has Genomic and Immunotherapy Medical Institute's research output changed?

Output in 2018–2022 was 538% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Dijon

All research institutions in Dijon

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.